7.62
-0.21(-2.68%)
Currency In USD
| Previous Close | 7.83 |
| Open | 7.84 |
| Day High | 7.88 |
| Day Low | 7.45 |
| 52-Week High | 23.2 |
| 52-Week Low | 3.5 |
| Volume | 2.49M |
| Average Volume | 9.92M |
| Market Cap | 771.51M |
| PE | -0.32 |
| EPS | -23.93 |
| Moving Average 50 Days | 9.01 |
| Moving Average 200 Days | 9.11 |
| Change | -0.21 |
If you invested $1000 in Tilray Brands, Inc. (TLRY) since IPO date, it would be worth $34.03 as of February 12, 2026 at a share price of $7.62. Whereas If you bought $1000 worth of Tilray Brands, Inc. (TLRY) shares 5 years ago, it would be worth $26.28 as of February 12, 2026 at a share price of $7.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals
GlobeNewswire Inc.
1 hours ago
CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital ChannelsNEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX:
Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois
GlobeNewswire Inc.
Feb 04, 2026 1:00 PM GMT
Award-winning spirits brand announce new distribution partner to oversee statewide distributionBRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brand
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany
GlobeNewswire Inc.
Feb 04, 2026 12:00 PM GMT
Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical MarketDENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TL